We aim to improve long-term outcomes for congenital-heart-disease patients using a regenerative medicine approach. Our tissue-engineered vascular graft develops into a neo vessel comprised of the patient’s own cells. Our goal is to make comparisons between our graft, the native vein, and the clinical standard polytetrafluoroethylene or PTFE.
We have established that our neo vessel displays growth capacity and that it approaches native vessel functionality. Using this method, we’ve also recently demonstrated that the neo vessel retains compliance and distensibility at a long-term time point, and is resistant to the formation of dystrophic calcification. Using 3D angiography allows us to image the entire path of the thoracic inferior vena cava in our ovine large-animal model.
In addition to allowing us to view the morphology of the vessel, it also allows for post-capture orientation adjustments to ensure we’re obtaining measurements from a true cross-section. Our in-vivo method allows us to determine the capacity for vessel compliance and distensibility in its native context. Additionally, it allows us to take longitudinal measurements of the same study animal, which is necessary to track changes in neo-vessel development and remodeling.
Villarreal, D. J., Watanabe, T., Nelson, K., Morrison, A., Heuer, E. D., Ulziibayar, A., Kelly, J. M., Breuer, C. K. Quantifying Inferior Vena Cava Compliance and Distensibility in an In Vivo Ovine Model Using 3D Angiography. J. Vis. Exp. (206), e66724, doi:10.3791/66724 (2024).